0000899243-15-005764.txt : 20151001 0000899243-15-005764.hdr.sgml : 20151001 20151001185447 ACCESSION NUMBER: 0000899243-15-005764 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151001 FILED AS OF DATE: 20151001 DATE AS OF CHANGE: 20151001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Novocure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER CITY: ST. HELIER STATE: Y9 ZIP: JE2 4YE REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Melnyk Peter M. CENTRAL INDEX KEY: 0001654442 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 151138165 MAIL ADDRESS: STREET 1: 1500 BROADWAY CITY: NEW YORK STATE: NY ZIP: 10036 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2015-10-01 0 0001645113 Novocure Ltd NVCR 0001654442 Melnyk Peter M. C/O NOVOCURE INC., 20 VALLEY STREAM PKWY SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Commercial Officer Options to Buy Ordinary Shares 3.44 2021-09-15 Ordinary Shares 76869 D Options to Buy Ordinary Shares 6.72 2021-09-15 Ordinary Shares 16260 D Options to Buy Ordinary Shares 7.03 2023-02-20 Ordinary Shares 41391 D Options to Buy Ordinary Shares 7.48 2024-02-26 Ordinary Shares 59130 D Options to Buy Ordinary Shares 14.37 2025-02-25 Ordinary Shares 177390 D Fully vested and currently exercisable as of the date hereof. Options to buy 20,695 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 20,696 ordinary shares will vest and become exercisable in equal installments on each of February 20, 2016 and 2017, subject to Mr. Melnyk's continued employment through such dates. Options to buy 14,782 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on each of February 26, 2016, 2017 and 2018, subject to Mr. Melnyk's continued employment through such dates. The options to buy 177,390 ordinary shares will vest and become exercisable in equal installments on each of February 25, 2016, 2017, 2018 and 2019, subject to Mr. Melnyk's continued employment through such dates. Exhibit 24 - Power of Attorney /s/ Todd Longsworth, Attorney in fact for Peter Melnyk 2015-10-01 EX-24 2 attachment1.htm EX-24 DOCUMENT
                          LIMITED POWER OF ATTORNEY FOR
                          SECTION 16 REPORTING PURPOSES

        Know all by these presents, that the undersigned hereby makes,
constitutes and appoints Todd Longsworth, acting individually, as the
undersigned's true and lawful attorney-in-fact, with full power and authority as
hereinafter described on behalf of and in the name, place and stead of the
undersigned to:

        (1) execute for, and on behalf of, the undersigned, in the undersigned's
capacity as an officer, director and/or 10% beneficial owner of Novocure Limited
(the "Company"), Forms 3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules and regulations promulgated
thereunder (the "Exchange Act");

        (2) seek or obtain, as the undersigned's representative and on the
undersigned's behalf, information on transactions in the Company's securities
from any third party, including brokers, employee benefit plan administrators
and trustees, and the undersigned hereby authorizes any such person to release
any such information to any attorney-in-fact and further approves and ratifies
any such release of information;

        (3) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to prepare, complete and execute any such
Form 3, 4 or 5, and any amendments thereto, or other required report and timely
file such Forms or reports with the United States Securities and Exchange
Commission, the New York Stock Exchange and any stock exchange or similar
authority as considered necessary or advisable under Section 16(a) of the
Exchange Act; and

        (4) take any other action of any type whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Limited Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact may approve in
such attorney-in-fact's sole discretion.

        The undersigned hereby gives and grants to each such attorney-in-fact
full power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise of any of
the rights and powers herein granted, as fully to all intents and purposes as
the undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.

        The undersigned hereby acknowledges that (a) the foregoing
attorneys-in-fact are serving in such capacity at the request of the
undersigned; (b) this Limited Power of Attorney authorizes, but does not
require, each such attorney-in-fact to act in his or her discretion on
information provided to such attorney-in-fact without independent verification
of such information; (c) any documents prepared and/or executed by any
attorney-in-fact on behalf of the undersigned pursuant to this Limited Power of
Attorney shall be in such form and shall contain such information and disclosure
as such attorney-in-fact, in his or her sole discretion, deems necessary or
advisable; (d) neither the Company nor any attorney-in-fact assumes (i) any
liability for the undersigned's responsibility to comply with the requirements
of the Exchange Act, (ii) any liability of the undersigned for any failure to
comply with such requirements or (iii) any obligation or liability of the
undersigned for profit disgorgement under Section 16(b) of the Exchange Act; and
(e) this Limited Power of Attorney does not relieve the undersigned from
responsibility for compliance with the undersigned's obligations under the
Exchange Act, including, without limitation, the reporting requirements under
Section 16 of the Exchange Act.

        This Limited Power of Attorney shall remain in full force and effect
until the undersigned is no longer required to file Forms 3, 4, and 5 with
respect to the undersigned's holdings of, and transactions in, securities issued
by the Company, unless earlier revoked as to any attorney-in-fact by the
undersigned in a signed writing delivered to such attorney-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to
be executed as of this 01 day of October, 2015.

                                                   /s/ Peter Melnyk
                                                  -----------------------------
                                                            Signature

                                                     Peter Melnyk
                                                  -----------------------------
                                                            Print Name